Loading market data...
Latest Top News
Pill Power: Lilly’s Daily Weight-Loss Drug Rivals Ozempic in Trial Triumph
Eli Lilly's once-daily weight-loss medication orforglipron provided 7.9% weight loss (16 lbs) at 40 weeks and also improved blood sugar control in type 2 diabetes patients, matching injectables like Ozempic in efficacy and safety. The Phase 3 study, the first of seven, lifted Lilly's shar...
Stay Ahead – Explore Now! Gold and Silver Prices Rebound in India as Peace Hopes Rise






